Concepedia
Statistics
Publications
23
Citations
1.8K
H-Index
17
Active since
1978
Affiliations
Nippon Medical School(Current)
Japan Clinical Cancer Research Organization
Osaka Prefectural Medical Center
Kinki Central Hospital
Shikoku Cancer Center
H Niitani is an author at Nippon Medical School specializing in oncology, medicine, and chemotherapy.
Publications per year
1978–2009
A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.
M. Fukuoka, H Niitani, Atsushi Suzuki et al. · Journal of Clinical Oncology · 1992 · 435 citations
Medicine, Oncology, Pharmacology +16
Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung Cancer
S. Negoro, M. Fukuoka, N Masuda et al. · JNCI Journal of the National Cancer Institute · 1991 · 274 citations
Medicine, Oncology, Pharmacology +14
Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer
Minoru Kawahara, Kiyoyuki Furuse, Yoshihiko Segawa et al. · British Journal of Cancer · 2001 · 214 citations · Full text
Medicine, Oncology, Pharmacology +15
Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer
Shunichi Negoro, N Masuda, Y Takada et al. · British Journal of Cancer · 2003 · 153 citations · Full text
Medicine, Oncology, Pharmacology +11
Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study.
Hideo Kunitoh, Kyohei Watanabe, T Onoshi et al. · Journal of Clinical Oncology · 1996 · 136 citations
Medicine, Oncology, Pharmacology +17
1–5 of 23